Procept BioRobotics Other Current Liabilities

Procept BioRobotics (PRCT) currently reports a other current liabilities of $31M as of March 2026. That compares with $25M in the prior-year period — up 22.1% year over year. Use the charts on this page to explore Procept BioRobotics's other current liabilities history and peer comparisons.

Procept BioRobotics's other current liabilities increased from $25M to $31M — a 22.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Procept BioRobotics reported $31M in other current liabilities as of March 2026. That compares with $25M in the prior-year period — up 22.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Procept BioRobotics, and consider following PRCT for alerts when major investors trade the stock.

Procept BioRobotics is classified in the Healthcare sector. On other current liabilities, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRCT with unrelated industries.